Körperliches Training bei pulmonaler Hypertonie – ein systematisches Review mit Metaanalyse

Zusammenfassung

Hintergrund Pulmonale Hypertonie (PH) ist definiert als ein Anstieg des mittleren pulmonal-arteriellen Drucks auf > 20 mmHg in Ruhe, der auf Dauer zu einer Rechtsherzinsuffizienz führen kann. Bis vor einigen Jahren wurde PH-Patienten wegen der Befürchtung einer möglichen Symptomverschlechterung und dem Auftreten unerwünschter, belastungsassoziierter klinischer Ereignisse von körperlichem Training abgeraten.

Methoden Drei elektronische Datenbanken wurden mit folgenden Suchbegriffen nach randomisiert, kontrollierten Studien durchsucht, in denen eine Trainingsintervention bei PH-Patienten untersucht wurde: „pulmonary hypertension ODER „pulmonary arterial hypertension“ UND „exercise“ ODER „pulmonary rehabilitation“ UND „randomized“.

Ergebnisse In dieser Metaanalyse konnten Daten von 5 Studien mit insgesamt 187 PH-Patienten eingeschlossen werden, welche 3- bis 12-wöchige Trainingsprogramme (z. B. 10 – 45 Minuten Ergometertraining; 60 – 80 % der maximalen Herzfrequenz) absolvierten. Patienten in den Trainingsgruppen wiesen im Vergleich zur Kontrollgruppe signifikante (p < 0,001) Verbesserungen ihrer körperlichen Belastbarkeit auf: 6-Minuten-Gehtest: + 45 m [95 % KI: 26 m – 64 m] oder maximale Sauerstoffaufnahme VO ₂ peak + 2,3 ml/kg/min [95 % KI: 1,8 ml/kg/min – 2,9 ml/kg/min]. Auch Komponenten der körperlichen und psychischen Lebensqualität verbesserten sich signifikant. Ernsthafte, unerwünschte Ereignisse im Rahmen der Trainingsinterventionen wurden nicht beobachtet.

Schlussfolgerung Ein individuell angepasstes Trainingsprogramm bei stabilen PH-Patienten kann nach zuvor optimierter medikamentöser Therapie die körperliche Belastbarkeit und Lebensqualität ohne nachweisbare klinische Gefährdung verbessern. Diese Einschätzungen basieren bisher nur auf kleinen Fallzahlen und größere, randomisierte Studien mit unterschiedlichen PH-Schweregraden sind dringend notwendig.

Abstract

Background Pulmonary hypertension (PH) is defined as an elevation of mean pulmonary-arterial pressure by > 20 mmHg at rest, which may lead to right heart failure. Physical exercise has not been regularly recommended for PH patients for fear of symptom deterioration or occurrence of exercise-induced adverse events.

Methods Three electronic databases were searched for randomized, controlled trials investigating exercise training in PH patients using the following keywords: “pulmonary hypertension” OR “pulmonary arterial hypertension” AND “exercise” OR “pulmonary rehabilitation” AND “randomized”.

Results Five studies involving 187 PH patients were included in this systematic review. Exercise programs lasted for 3 – 12 weeks (e. g. endurance training for 10 – 45 minutes; 60 – 80 % of the peak heart rate). PH patients significantly improved exercise capacity compared to controls in 6-minute walk distance (+ 45 m; 95 % CI: 26 m – 64 m) or peak oxygen consumption (+ 2.3 ml/kg/min; 95 % CI: 1.8 – 2.9 ml/kg/min), both p < 0.001. Also, physical and mental quality of life improved significantly by exercise training. No exercise-induced adverse events were observed.

Conclusion Supervised exercise training can safely and significantly improve physical performance and quality of life in clinically stable PH patients with optimal drug treatment. However, larger studies including a wider range of PH are mandatory.

• Literatur

• 1 Simonneau G, Montani D, Celermajer DS. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;
• 2 Tuder RM, Archer SL, Dorfmuller P. et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D4-D12
• 3 Hoeper MM, Humbert M, Souza R. et al. A global view of pulmonary hypertension. Lancet Respir Med 2016; 4: 306-322
• 4 Simonneau G, Gatzoulis MA, Adatia I. et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D34-D41
• 5 Galie N, Humbert M, Vachiery JL. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67-119
• 6 Hoeper MM, Kramer T, Pan Z. et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J 2017;
• 7 Kovacs G, Berghold A, Scheidl S. et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009; 34: 888-894
• 8 Tolle JJ, Waxman AB, Van Horn TL. et al. Exercise-induced pulmonary arterial hypertension. Circulation 2008; 118: 2183-2189
• 9 Nootens M, Wolfkiel CJ, Chomka EV. et al. Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. Am J Cardiol 1995; 75: 374-377
• 10 Galie N, Corris PA, Frost A. et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 2013; 62: D60-D72
• 11 Ellingsen O, Halle M, Conraads V. et al. High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction. Circulation 2017; 135: 839-849
• 12 O’Connor CM, Whellan DJ, Lee KL. et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. Jama 2009; 301: 1439-1450
• 13 Huppmann P, Sczepanski B, Boensch M. et al. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J 2013; 42: 444-453
• 14 Spruit MA, Singh SJ, Garvey C. et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13-e64
• 15 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-1012
• 16 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from: www.handbook.cochrane.org
• 17 Ehlken N, Lichtblau M, Klose H. et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. Eur Heart J 2016; 37: 35-44
• 18 Gonzalez-Saiz L, Fiuza-Luces C, Sanchis-Gomar F. et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: The WHOLEi+12 trial. Int J Cardiol 2017; 231: 277-283
• 19 Ley S, Fink C, Risse F. et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. Eur Radiol 2013; 23: 324-331
• 20 Mereles D, Ehlken N, Kreuscher S. et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 2006; 114: 1482-1489
• 21 Weinstein AA, Chin LM, Keyser RE. et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respir Med 2013; 107: 778-784
• 22 Chan L, Chin LMK, Kennedy M. et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest 2013; 143: 333-343
• 23 Babu AS, Padmakumar R, Maiya AG. et al. Effects of Exercise Training on Exercise Capacity in Pulmonary Arterial Hypertension: A Systematic Review of Clinical Trials. Heart Lung Circ 2016; 25: 333-341
• 24 Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet 1998; 352: 719-725
• 25 Waxman AB. Exercise physiology and pulmonary arterial hypertension. Prog Cardiovasc Dis 2012; 55: 172-179
• 26 Holland AE, Spruit MA, Troosters T. et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44: 1428-1446
• 27 Grunig E, Eichstaedt C, Barbera JA. et al. ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension. Eur Respir J 2019; 53
• 28 Handoko ML, de Man FS, Happe CM. et al. Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation 2009; 120: 42-49
• 29 Colombo R, Siqueira R, Becker CU. et al. Effects of exercise on monocrotaline-induced changes in right heart function and pulmonary artery remodeling in rats. Can J Physiol Pharmacol 2013; 91: 38-44
• 30 Blumberg FC, Arzt M, Lange T. et al. Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension. Eur J Heart Fail 2013; 15: 771-775
• 31 Malenfant S, Potus F, Mainguy V. et al. Impaired Skeletal Muscle Oxygenation and Exercise Tolerance in Pulmonary Hypertension. Med Sci Sports Exerc 2015; 47: 2273-2282
• 32 de Man FS, Handoko ML, Groepenhoff H. et al. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2009; 34: 669-675
• 33 Rosenkranz S, Diller GP, Dumitrescu D. et al. Hämodynamische Definition der pulmonalen Hypertonie: Kommentar zu der vorgeschlagenen Änderung durch das 6th World Symposium on Pulmonary Hypertension. Dtsch Med Wochenschr 2019;
• 34 Piepoli MF, Corra U, Adamopoulos S. et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol 2014; 21: 664-681
• 35 Richter MJ, Grimminger J, Kruger B. et al. Effects of exercise training on pulmonary hemodynamics, functional capacity and inflammation in pulmonary hypertension. Pulm Circ 2017; 7: 20-37
• 36 Morris NR, Seale H, Harris J. et al. Serious adverse events during a 6-min walk test in patients with pulmonary hypertension. Eur Respir J 2015; 45: 1179-1182
• 37 Grunig E, Eichstaedt C, Barbera JA. et al. ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension. Eur Respir J 2019; Feb 28; 53(2): pii: 1800332
• 38 Grunig E, Lichtblau M, Ehlken N. et al. Safety and Efficacy of Exercise Training in various forms of Pulmonary Hypertension. Eur Respir J 2012; 40: 84-92
• 39 Vaes AW, Garcia-Aymerich J, Marott JL. et al. Changes in physical activity and all-cause mortality in COPD. Eur Respir J 2014; 44: 1199-1209
• 40 Waschki B, Kirsten A, Holz O. et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140: 331-342
• 41 Eijsvogels TM, Molossi S, Lee DC. et al. Exercise at the Extremes: The Amount of Exercise to Reduce Cardiovascular Events. J Am Coll Cardiol 2016; 67: 316-329
• 42 Cascino TM, McLaughlin VV, Richardson CR. et al. Physical activity and quality of life in patients with pulmonary hypertension. Eur Respir J 2019; 53
• 43 Cascino TM, McLaughlin VV, Richardson CR. et al. Barriers to physical activity in patients with pulmonary hypertension. Pulm Circ 2019; 9: 2045894019847895
• 44 Hoeper MM, Ghofrani HA, Grunig E. et al. Pulmonary Hypertension. Dtsch Arztebl Int 2017; 114: 73-84